PIM2 survival kinase is upregulated in a p53-dependent manner in cells treated with camptothecin or co-treated with actinomycin D and nutlin-3a.
Authors: Artur Zajkowicz, Małgorzata Krześniak, Agnieszka Gdowicz-Kłosok, Barbara Łasut, Marek Rusin
Published in: Archives of Biochemistry and Biophysics
Publication type: article
Subject areas: Biochemistry, Genetics and Molecular Biology
SJR best quartile: Q1